-
BioJet LLC Obtains License for Pharmaceutical Production
Read more: BioJet LLC Obtains License for Pharmaceutical ProductionIn November 2025, the production facility of BioJet LLC in Pechatniki successfully passed an inspection by the Russian Ministry of Industry and Trade. Based on the results, the company was granted a License to manufacture medicinal pharmaceutical products. License registration number: L012-00102-77/03725316, issued on November 13, 2025.
-
MedSafetyWeek Global Pharmacotherapy Safety Week Launched Worldwide
Read more: MedSafetyWeek Global Pharmacotherapy Safety Week Launched WorldwideThe Russian Federation supports the initiative of the Uppsala Monitoring Centre of the WHO (UMC) and participates in the annual awareness campaign dedicated to the safe use of medicines — MedSafetyWeek. Traditionally held during the first week of November, national regulatory authorities from 117 countries worldwide encourage healthcare professionals, pharmacists, and patients to report adverse…
-
Government to Review Draft Law on Improving Medicine Imports under Sanctions
Read more: Government to Review Draft Law on Improving Medicine Imports under SanctionsThe Russian government will consider a draft federal law “On Amending Article 47 of the Federal Law ‘On the Circulation of Medicines’” at a meeting on Thursday, according to the government press service. “The bill is aimed at improving the legal regulation of relations concerning the import of medicinal products for medical use into the…
-
Russia to Complete Transition to EAEU GMP Rules by March 2026
Read more: Russia to Complete Transition to EAEU GMP Rules by March 2026The Russian government has recognized the national rules for inspecting pharmaceutical manufacturers for compliance with Good Manufacturing Practice (GMP) as invalid. In addition to three government resolutions related to GMP certification, clause 36 of the state services list — concerning the inspection of pharmaceutical companies producing medicines outside Russia — will also be repealed. The…
-
Government Updates Rules for State Control in the Circulation of Medicines
Read more: Government Updates Rules for State Control in the Circulation of MedicinesThe Russian government has approved amendments developed by the Ministry of Health to the Regulation on Federal State Control (Oversight) in the Circulation of Medicinal Products. The document abolishes scheduled inspections for entities classified as significant, medium, or moderate risk, and sets the frequency of preventive visits based on risk category. The regulation also establishes…
-
Regulatory Updates. Industry Legal Acts of October 2025
Read more: Regulatory Updates. Industry Legal Acts of October 2025At the request of Vademecum, the Pharmaceuticals & Healthcare Practice of VERBA LEGAL prepared an overview of the regulatory legal acts (RLAs) that entered into force in October 2025 and concern the circulation of medicines and medical devices. In addition, the lawyers highlighted several documents that will take effect later, as well as draft regulatory…
-
Takeda Finds Buyer for Its Yaroslavl Manufacturing Facility
Read more: Takeda Finds Buyer for Its Yaroslavl Manufacturing FacilityJapanese pharmaceutical company Takeda has received approval from the Russian Government Commission for Control over Foreign Investments to sign an agreement with Binergiya JSC. Under the deal, Takeda plans to transfer rights to commercialize part of its retail drug portfolio — which is considered non-core for the company — as well as its production site…
-
What Pharmaceutical Sovereignty Will Look Like in Russia
Read more: What Pharmaceutical Sovereignty Will Look Like in RussiaThe development of a full-cycle pharmaceutical industry in Russia is seen as the key to long-term drug security and the country’s technological sovereignty. Achieving this requires coordinated efforts among regulators, businesses, and the scientific community. GxP News explored which development priorities each side considers most important. The geopolitical challenges of recent years have pushed the…
-
Crystalline DNA “Flowers” Created for Targeted Drug Delivery
Read more: Crystalline DNA “Flowers” Created for Targeted Drug DeliveryThey can unfold and fold up to ten times, enabling multiple uses. American chemists have developed nanocrystals made from DNA strands and inorganic molecules that can repeatedly open and close in response to changes in environmental conditions — much like flowers do. This property allows the DNA “flowers” to be used for packaging and targeted…
-
Healthy Lifestyle vs. “Magic Pills”: How Russia Is Working to Extend Life Expectancy
Read more: Healthy Lifestyle vs. “Magic Pills”: How Russia Is Working to Extend Life ExpectancyRussia’s Minister of Health, Mikhail Murashko, has called for a reconsideration of traditional views on aging. According to him, the key priorities for modern healthcare are extending healthy life expectancy and slowing the progression of diseases — including through the use of digital technologies. Earlier, social media was abuzz with claims that some people could…